Medicare Enrolled
Dr. Brian Sprandio, M.D.
Family Medicine · Bryn Mawr, PA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Sprandio from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Sprandio?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Sprandio
Dr. Brian Sprandio is a family medicine specialist in Bryn Mawr, PA, with 11 years of NPI registration. Based on federal Medicare data, Dr. Sprandio performed 837 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Sprandio received a total of $5,909 from 57 pharmaceutical and/or device companies across 252 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Sprandio is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 11 years of NPI registration
▲ Top 33% volume in PA
$5,909 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗837
Medicare services
Top 33% in PA for family medicine
Not available
Unique patients (not deduplicated)
$100
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
512 | $103 | $224 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
110 | $143 | $301 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
90 | $73 | $148 |
| Advance care planning consultation, first 30 min A session focused on discussing and documenting future healthcare preferences and goals. This service covers the initial 30 minutes of the planning discussion. |
80 | $68 | $189 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
30 | $98 | $232 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
15 | $8 | $30 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$5,909
Total received (2021-2024)
Avg $1,477/year across 4 years
Top 10% in PA for family medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
57
Companies
252
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,861
2023
$2,128
2022
$869
2021
$51
Payments by company (2024)
SHIELD THERAPEUTICS INC
$567
AstraZeneca Pharmaceuticals LP
$222
E.R. Squibb & Sons, L.L.C.
$171
Novartis Pharmaceuticals Corporation
$151
Takeda Pharmaceuticals U.S.A., Inc.
$142
Janssen Biotech, Inc.
$120
Bayer Healthcare Pharmaceuticals Inc.
$118
Genmab U.S., Inc.
$94
ARRAY BIOPHARMA INC
$77
Merck Sharp & Dohme LLC
$75
Incyte Corporation
$72
Genentech USA, Inc.
$66
PFIZER INC.
$65
Ipsen Biopharmaceuticals, Inc
$64
Eisai Inc.
$63
Celgene Corporation
$63
Sumitomo Pharma America, Inc.
$51
Mirati Therapeutics, Inc.
$51
SERVIER PHARMACEUTICALS LLC
$49
GlaxoSmithKline, LLC.
$48
Aveo Pharmaceuticals, Inc.
$48
Daiichi Sankyo Inc.
$40
Gilead Sciences, Inc.
$36
Rigel Pharmaceuticals, Inc.
$36
Grifols USA, LLC
$30
Regeneron Healthcare Solutions, Inc.
$27
Kite Pharma, Inc.
$27
Amneal Pharmaceuticals LLC
$26
GENZYME CORPORATION
$25
Stemline Therapeutics Inc.
$24
Blueprint Medicines Corporation
$24
BeiGene USA, Inc.
$23
PharmaEssentia USA Corporation
$23
Astellas Pharma US Inc
$22
PUMA BIOTECHNOLOGY, INC.
$22
Boehringer Ingelheim Pharmaceuticals, Inc.
$22
SOBI, INC
$21
ABBVIE INC.
$20
EMD Serono, Inc.
$18
Alexion Pharmaceuticals, Inc.
$18
Top 3 companies account for 33.5% of 2024 payments
All-time payments by company (2021-2024) ›
SHIELD THERAPEUTICS INC
$567
AstraZeneca Pharmaceuticals LP
$502
E.R. Squibb & Sons, L.L.C.
$439
Novartis Pharmaceuticals Corporation
$390
Celltrion USA Inc.
$287
Genmab U.S., Inc.
$240
Merck Sharp & Dohme LLC
$204
Takeda Pharmaceuticals U.S.A., Inc.
$190
GENZYME CORPORATION
$187
Janssen Biotech, Inc.
$186
Bayer Healthcare Pharmaceuticals Inc.
$156
Mirati Therapeutics, Inc.
$144
PFIZER INC.
$130
ARRAY BIOPHARMA INC
$114
Celgene Corporation
$109
Genentech USA, Inc.
$108
Daiichi Sankyo Inc.
$98
Regeneron Healthcare Solutions, Inc.
$97
Incyte Corporation
$93
Eisai Inc.
$87
GlaxoSmithKline, LLC.
$86
Ipsen Biopharmaceuticals, Inc
$83
Seagen Inc.
$82
Blueprint Medicines Corporation
$80
Kite Pharma, Inc.
$75
PharmaEssentia USA Corporation
$72
Stemline Therapeutics Inc.
$68
Amgen Inc.
$63
AVEO Pharmaceuticals, Inc.
$63
SOBI, INC
$63
Fresenius Kabi USA, LLC
$56
Rigel Pharmaceuticals, Inc.
$53
Sumitomo Pharma America, Inc.
$51
SERVIER PHARMACEUTICALS LLC
$49
Aveo Pharmaceuticals, Inc.
$48
Astellas Pharma US Inc
$47
TerSera Therapeutics LLC
$44
Bayer HealthCare Pharmaceuticals Inc.
$39
EISAI INC.
$39
Gilead Sciences, Inc.
$36
EMD Serono, Inc.
$32
Alexion Pharmaceuticals, Inc.
$30
Grifols USA, LLC
$30
Pharmacyclics LLC, An AbbVie Company
$30
Myovant Sciences Inc.
$27
Amneal Pharmaceuticals LLC
$26
G1 Therapeutics, Inc.
$24
BeiGene USA, Inc.
$23
PUMA BIOTECHNOLOGY, INC.
$22
Boehringer Ingelheim Pharmaceuticals, Inc.
$22
Puma Biotechnology, Inc.
$21
ABBVIE INC.
$20
Sobi, Inc
$17
AbbVie Inc.
$16
ADC Therapeutics America, Inc.
$16
Exelixis Inc.
$15
Spectrum Pharmaceuticals Inc.
$14
Top 3 companies account for 25.5% of all-time payments
Associated products mentioned in payments ›
ACCRUFER · ADCETRIS · ALUNBRIG · AVASTIN · AYVAKIT · Alecensa · BAVENCIO · BESREMI · BRAFTOVI · BRUKINSA · CALQUENCE · CAMZYOS · CARVYKTI · COSELA · Cabometyx · DOPTELET · Doptelet · ELIQUIS · ELITEK · ENHERTU · ENJAYMO · ERLEADA · Enhertu · Epkinly · Erivedge · FOTIVDA · FRUZAQLA · Fabhalta · GAVRETO · Gamunex-C · Halaven · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INLYTA · Itovebi · JAKAFI · JEMPERLI · JEVTANA · KEYTRUDA · KISQALI · KRAZATI · Kabiven · LIBTAYO · LORBRENA · LUPRON DEPOT · LUTATHERA · LYNPARZA · Lenvima · MEKINIST · MONJUVI · NERLYNX · NINLARO · Nplate · Nubeqa · OJJAARA · OPDIVO · OPDUALAG · ORGOVYX · Onivyde · Orserdu · PADCEV · PEMAZYRE · PLUVICTO · PROMACTA · Padcev · Pomalyst · REBLOZYL · ROLVEDON · RYBREVANT · Rezlidhia · SARCLISA · SCEMBLIX · SOMATULINE DEPOT · Stivarga · TAGRISSO · TASIGNA · TIVDAK · TUKYSA · Tibsovo · Tivdak · ULTOMIRIS · VEGZELMA · VENCLEXTA · Venclexta · Voranigo · Xermelo · Yescarta · Zoladex
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Family medicine physicians in nearby ZIP areas
2,480
County median income
$88,576
Nearest hospital to ZIP centroid (approximate)
BRYN MAWR HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Sprandio is a clinical cardiology specialist, with moderate Medicare volume.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Sprandio experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Sprandio performed 512 office visit, established patient (30-39 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Sprandio receive payments from pharmaceutical companies?
Yes. Dr. Sprandio received a total of $5,909 from 57 companies across 252 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Sprandio's costs compare to other family medicine physicians in Bryn Mawr?
Dr. Sprandio's average Medicare payment per service is $100. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Sprandio) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Family Medicine
Common procedures, typical costs, and what industry payments mean in family medicine.
Same specialty & city
Family Medicine Physicians in Bryn Mawr
Browse family medicine physicians in Bryn Mawr ranked by procedure volume and transparency data.
Highest volume
Top Family Medicine Physicians in PA
Family medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Family Medicine Physicians in PA
Which PA family medicine physicians receive the most from drug and device companies.
By company
SHIELD THERAPEUTICS INC Payments to Doctors
See all physicians who received payments from SHIELD THERAPEUTICS INC.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology